Subtopic Deep Dive
Niemann-Pick Disease Pathophysiology
Research Guide
What is Niemann-Pick Disease Pathophysiology?
Niemann-Pick disease pathophysiology encompasses sphingomyelin accumulation due to acid sphingomyelinase deficiency in types A/B and cholesterol/glycosphingolipid trafficking defects in type C, leading to lysosomal dysfunction.
Types A and B result from SMPD1 mutations causing sphingomyelin buildup (Horinouchi et al., 1995, 476 citations). Type C involves NPC1/NPC2 defects impairing late endosome-lysosome lipid transport (Vanier, 2010, 1178 citations). Over 50 papers detail cellular models and mouse phenotypes.
Why It Matters
Understanding Niemann-Pick pathophysiology enables substrate reduction therapies, as cyclodextrin treatment reduces neuronal cholesterol storage and extends lifespan in Npc1-/- mice (Davidson et al., 2009, 447 citations). Lysosomal calcium deregulation in NPC1 drives neurodegeneration, informing gene therapy targets (Lloyd-Evans et al., 2008, 824 citations). Insights guide enzyme replacement for types A/B (Horinouchi et al., 1995).
Key Research Challenges
Modeling Type C Lipid Trafficking
NPC1/NPC2 defects disrupt cholesterol egress from late endosomes, complicating in vitro models (Vanier, 2010). Rab proteins correct glycosphingolipid transport in NPC cells via Golgi pathways (Choudhury et al., 2002, 417 citations). Animal models show incomplete phenotype rescue.
Sphingomyelinase Deficiency Mechanisms
Acid sphingomyelinase knockout mice replicate types A/B lipid accumulation but lack full neurodegeneration (Horinouchi et al., 1995). Enzymology regulation remains unclear despite sphingomyelin updates (Merrill and Jones, 1990, 458 citations). Secondary calcium defects emerge in type C.
Translating Therapies to Humans
Cyclodextrin ameliorates murine NPC but fails full cholesterol correction (Davidson et al., 2009). Lysosome targeting faces delivery barriers (Bonam et al., 2019, 718 citations). LSD pathophysiology varies across types (Parenti et al., 2015, 398 citations).
Essential Papers
Niemann-Pick disease type C
Marie T. Vanier · 2010 · Orphanet Journal of Rare Diseases · 1.2K citations
Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
Emyr Lloyd‐Evans, Anthony J. Morgan, Xingxuan He et al. · 2008 · Nature Medicine · 824 citations
Lysosomes as a therapeutic target
Srinivasa Reddy Bonam, Fengjuan Wang, Sylviane Muller · 2019 · Nature Reviews Drug Discovery · 718 citations
Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease
Kenichi Horinouchi, Shai Erlich, Daniel P. Perl et al. · 1995 · Nature Genetics · 476 citations
An update of the enzymology and regulation of sphingomyelin metabolism
Alfred H. Merrill, Dean Jones · 1990 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 458 citations
Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
Cristin Davidson, Nafeeza Ali, Matthew C. Micsenyi et al. · 2009 · PLoS ONE · 447 citations
Treatment with CD delayed clinical disease onset, reduced intraneuronal storage and secondary markers of neurodegeneration, and significantly increased lifespan of both Npc1(-/-) and Npc2(-/-) mice...
Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells
Amit Choudhury, Michel Dominguez, Vishwajeet Puri et al. · 2002 · Journal of Clinical Investigation · 417 citations
We recently showed that human skin fibroblasts internalize fluorescent analogues of the glycosphingolipids lactosylceramide and globoside almost exclusively by a clathrin-independent mechanism invo...
Reading Guide
Foundational Papers
Start with Vanier (2010) for type C overview (1178 citations), Horinouchi et al. (1995) for A/B models (476 citations), then Lloyd-Evans et al. (2008) for calcium mechanisms (824 citations).
Recent Advances
Parenti et al. (2015, 398 citations) updates LSD therapies; Bonam et al. (2019, 718 citations) targets lysosomes.
Core Methods
Smpd1-/- mouse models (Horinouchi et al., 1995); cyclodextrin lipid reduction (Davidson et al., 2009); Rab-mediated glycosphingolipid tracking (Choudhury et al., 2002); lysosomal calcium assays (Lloyd-Evans et al., 2008).
How PapersFlow Helps You Research Niemann-Pick Disease Pathophysiology
Discover & Search
Research Agent uses citationGraph on Vanier (2010) to map 1178-cited NPC reviews, then findSimilarPapers for type C trafficking studies like Lloyd-Evans et al. (2008). exaSearch queries 'NPC1 lysosomal calcium sphingosine' to uncover 200+ related papers beyond OpenAlex indexes.
Analyze & Verify
Analysis Agent runs readPaperContent on Horinouchi et al. (1995) to extract mouse model phenotypes, verifies sphingomyelin accumulation claims via CoVe against Merrill and Jones (1990), and uses runPythonAnalysis for lipid storage statistics with pandas on abstract data. GRADE grading scores evidence strength for therapy translation.
Synthesize & Write
Synthesis Agent detects gaps in type C Rab protein therapies post-Choudhury et al. (2002), flags contradictions in cyclodextrin efficacy (Davidson et al., 2009). Writing Agent applies latexEditText for pathophysiology diagrams, latexSyncCitations for 10-paper reviews, and latexCompile for submission-ready manuscripts; exportMermaid visualizes lipid trafficking pathways.
Use Cases
"Analyze sphingomyelin levels in acid sphingomyelinase knockout mice from Horinouchi 1995."
Analysis Agent → readPaperContent (Horinouchi et al., 1995) → runPythonAnalysis (pandas plot of storage data from abstract) → statistical verification output with p-values and GRADE score.
"Write LaTeX review on NPC1 calcium dysregulation mechanisms."
Synthesis Agent → gap detection (Lloyd-Evans et al., 2008) → Writing Agent → latexEditText (intro section) → latexSyncCitations (10 papers) → latexCompile → PDF with mermaid lipid flow diagram.
"Find code for Niemann-Pick mouse model simulations."
Research Agent → paperExtractUrls (Davidson et al., 2009) → paperFindGithubRepo → githubRepoInspect → Python scripts for cholesterol storage modeling shared via exportCsv.
Automated Workflows
Deep Research workflow scans 50+ LSD papers via searchPapers on 'Niemann-Pick pathophysiology', chains citationGraph → findSimilarPapers → structured report on type A/B/C mechanisms. DeepScan applies 7-step CoVe to verify cyclodextrin claims (Davidson et al., 2009) with GRADE checkpoints. Theorizer generates hypotheses on Rab-Golgi corrections for NPC from Choudhury et al. (2002).
Frequently Asked Questions
What defines Niemann-Pick disease pathophysiology?
Sphingomyelin accumulation from acid sphingomyelinase deficiency in types A/B (Horinouchi et al., 1995) and cholesterol trafficking failure in type C via NPC1/NPC2 (Vanier, 2010).
What are key methods in Niemann-Pick research?
Mouse models like acid sphingomyelinase knockouts (Horinouchi et al., 1995) and cyclodextrin treatment assays (Davidson et al., 2009); fluorescent lipid analogs track caveolae-Golgi transport (Choudhury et al., 2002).
What are seminal papers?
Vanier (2010, 1178 citations) reviews type C; Lloyd-Evans et al. (2008, 824 citations) links NPC1 to lysosomal calcium; Horinouchi et al. (1995, 476 citations) establishes type A/B models.
What open problems persist?
Incomplete therapy translation from mice to humans (Davidson et al., 2009); unclear sphingomyelin regulation (Merrill and Jones, 1990); lysosome delivery barriers (Bonam et al., 2019).
Research Lysosomal Storage Disorders Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Niemann-Pick Disease Pathophysiology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers